The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial.

Zojaji, Homayoun; Ghobakhlou, Mehdi; Rajabalinia, Hassan; Ataei, Elnaz; Jahani Sherafat, Somayeh; Moghimi-Dehkordi, Bijan; Bahreiny, Rasoul

Zojaji, Homayoun; Ghobakhlou, Mehdi; Rajabalinia, Hassan; Ataei, Elnaz; Jahani Sherafat, Somayeh; Moghimi-Dehkordi, Bijan; Bahreiny, Rasoul.

Afiliación

Zojaji H; Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Ghobakhlou M; Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Rajabalinia H; Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Ataei E; Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Jahani Sherafat S; Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Moghimi-Dehkordi B; Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Bahreiny R; Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.

Gastroenterol Hepatol Bed Bench ; 6(Suppl 1): S99-S104, 2013.

Article en En | MEDLINE | ID: mdl-24834296

Palabras clave

Anti-helicobacter pylori eradication therapy; Helicobacter pylori; Probiotic; Saccharomyces boulardii

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Gastroenterol Hepatol Bed Bench Año: 2013 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google